Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 2 | $27,525,465 |
Sells | 23 | $168,989 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
16 Feb 2024 21:48 | MCRB | Seres Therapeutics Inc | DESROSIER THOMAS | Chief Legal Officer and EVP | 16 Feb 2024 | Sale | 3,939 | 1.08 | 4,254 | D |
16 Feb 2024 21:42 | MCRB | Seres Therapeutics Inc | SHAFF ERIC D. | CEO and President | 16 Feb 2024 | Sale | 11,549 | 1.08 | 12,473 | D |
16 Feb 2024 21:29 | MCRB | Seres Therapeutics Inc | YOUNG TERESA L. | See Remarks | 16 Feb 2024 | Sale | 3,374 | 1.08 | 3,644 | D |
16 Feb 2024 21:31 | MCRB | Seres Therapeutics Inc | HENN MATTHEW R. | See Remarks | 16 Feb 2024 | Sale | 4,170 | 1.08 | 4,504 | D |
16 Feb 2024 21:21 | MCRB | Seres Therapeutics Inc | VON MOLTKE LISA | See Remarks | 16 Feb 2024 | Sale | 4,400 | 1.08 | 4,752 | D |
16 Feb 2024 21:15 | MCRB | Seres Therapeutics Inc | EGE DAVID S. | See Remarks | 16 Feb 2024 | Sale | 5,010 | 1.08 | 5,411 | D |
16 Feb 2024 21:13 | MCRB | Seres Therapeutics Inc | ARKOWITZ DAVID | Chief Financial Officer | 16 Feb 2024 | Sale | 3,939 | 1.08 | 4,254 | D |
31 Oct 2023 21:40 | MCRB | Seres Therapeutics Inc | YOUNG TERESA L. | See Remarks | 30 Oct 2023 | Sale | 2,907 | 1.35 | 3,924 | D |
31 Oct 2023 21:40 | MCRB | Seres Therapeutics Inc | SHAFF ERIC D. | CEO and President | 30 Oct 2023 | Sale | 8,552 | 1.35 | 11,545 | D |
31 Oct 2023 21:43 | MCRB | Seres Therapeutics Inc | CLOGHESSY PAULA | See Remarks | 30 Oct 2023 | Sale | 2,904 | 1.35 | 3,920 | D |
31 Oct 2023 21:36 | MCRB | Seres Therapeutics Inc | HENN MATTHEW R. | See Remarks | 30 Oct 2023 | Sale | 3,886 | 1.35 | 5,246 | D |
31 Oct 2023 21:36 | MCRB | Seres Therapeutics Inc | VON MOLTKE LISA | See Remarks | 30 Oct 2023 | Sale | 4,232 | 1.35 | 5,713 | D |
31 Oct 2023 21:39 | MCRB | Seres Therapeutics Inc | EGE DAVID S. | See Remarks | 30 Oct 2023 | Sale | 4,066 | 1.35 | 5,489 | D |
31 Oct 2023 21:39 | MCRB | Seres Therapeutics Inc | DESROSIER THOMAS | Chief Legal Officer and EVP | 30 Oct 2023 | Sale | 4,156 | 1.35 | 5,611 | D |
31 Oct 2023 21:39 | MCRB | Seres Therapeutics Inc | ARKOWITZ DAVID | Chief Financial Officer | 30 Oct 2023 | Sale | 4,066 | 1.35 | 5,489 | D |
17 May 2024 20:23 | MCRB | Seres Therapeutics Inc | VON MOLTKE LISA | See Remarks | 15 May 2024 | Sale | 939 | 0.94 | 883 | D |
17 May 2024 20:14 | MCRB | Seres Therapeutics Inc | DESROSIER THOMAS | Chief Legal Officer and EVP | 15 May 2024 | Sale | 843 | 0.94 | 792 | D |
17 May 2024 20:16 | MCRB | Seres Therapeutics Inc | EGE DAVID S. | See Remarks | 15 May 2024 | Sale | 1,090 | 0.94 | 1,025 | D |
17 May 2024 20:17 | MCRB | Seres Therapeutics Inc | HENN MATTHEW R. | See Remarks | 15 May 2024 | Sale | 891 | 0.94 | 838 | D |
17 May 2024 20:18 | MCRB | Seres Therapeutics Inc | YOUNG TERESA L. | See Remarks | 15 May 2024 | Sale | 703 | 0.94 | 661 | D |
17 May 2024 20:18 | MCRB | Seres Therapeutics Inc | SHAFF ERIC D. | CEO and President | 15 May 2024 | Sale | 2,435 | 0.94 | 2,289 | D |
01 May 2023 16:46 | MCRB | Seres Therapeutics Inc | EGE DAVID S. | See Remarks | 28 Apr 2023 | Sale | 7,038 | 5.19 | 36,527 | D |
31 Oct 2022 19:37 | MCRB | Seres Therapeutics Inc | EGE DAVID S. | See Remarks | 31 Oct 2022 | Sale | 5,012 | 7.93 | 39,745 | D |
07 Jul 2022 17:00 | MCRB | Seres Therapeutics Inc | NUTRITIONAL HEALTH LTP FUND GENERAL PARTNER LLC | 10% | 05 Jul 2022 | Purchase | 5,825,495 | 3.15 | 18,350,309 | I |
07 Jul 2022 17:00 | MCRB | Seres Therapeutics Inc | NUTRITIONAL HEALTH LTP FUND GENERAL PARTNER LLC | 10% | 05 Jul 2022 | Purchase | 2,912,748 | 3.15 | 9,175,156 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)